Zya

Enzymatic detoxification of mycotoxins using cofactor-independent enzymes

Technology
Conceptual
Company

Innovative enzyme cocktail for detoxifying major mycotoxins in corn without costly cofactors. Utilizes robust hydrolases to convert toxic compounds into non-toxic metabolites during processing. Suitable for scalable industrial applications.

Overview

The enzymatic detoxification solution developed by Zya offers a novel approach to managing mycotoxin contamination in corn. By employing a multi-functional panel of robust, cofactor-independent hydrolases, this solution effectively neutralizes major toxins such as Zearalenone, Ochratoxin A, and Aflatoxin B1. These enzymes, including esterases, amidases, lactonases, and epoxide hydrolases, target the molecular structures of the toxins, converting them into harmless, polar metabolites. This method circumvents the need for costly cofactor regeneration, making it economically viable for large-scale corn processing operations.

Technical specifications
  • Cofactor-independent enzymes: Utilizes hydrolases that do not require expensive cofactors, reducing costs and complexity.
  • Broad-spectrum activity: Targets a wide range of mycotoxins by focusing on key molecular "warheads."
  • Standard processing conditions: Effective under typical aqueous conditions during grain steeping or milling.
  • Non-toxic byproducts: Converts harmful contaminants into non-toxic metabolites without external chemical additives.
  • Scalable solution: Designed for integration into industrial processing lines.
Technology readiness level

This innovative solution is currently at Technology Readiness Level 3, indicating experimental proof of concept has been established. Future development will focus on enzyme panel assembly, recombinant expression, high-throughput screening, analytical profiling, and optimization for industrial application.


About Zya

A young food-tech startup founded in 2020, focused on metabolic engineering solutions for nutrition. Zya emerged from university research and incubators, developing the Convero enzyme platform to tackle excess sugar consumption by leveraging human biology.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.